Viking Therapeutics, Inc.
Viking Therapeutics, Inc.
Explore linked clinical trials.6 results ยท Page 1 of 1
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Oral VK2735 for Weight Management in Adults With Type 2 Diabetes Mellitus Phase 3 (SUNRISE 2) | Body Weight, Body Weight Changes, Pathological Conditions, Signs and Symptoms, Signs and Symptoms, Weight Loss | Not yet recruiting | Phase 3 | 2026-10-09 | NCT07868939 | |
| Oral VK2735 for Weight Management Phase 3 (SUNRISE 1) | Body Weight, Body Weight Changes, Pathological Conditions, Signs and Symptoms, Signs and Symptoms, Weight Loss | Not yet recruiting | Phase 3 | 2026-10-09 | NCT07868835 | |
| A Phase 1 Study of VK3019 in Overweight and Obese Adults Without Comorbidities | Body Weight, Body Weight Changes, Pathological Conditions, Signs and Symptoms, Signs and Symptoms, Weight Loss | Recruiting | Phase 1 | 2026-09-29 | NCT07846033 | |
| A Phase 1 Study of VK2735 in Obese Adults Without Comorbidities | Body Weight, Body Weight Changes, Pathological Conditions, Signs and Symptoms, Signs and Symptoms, Weight Loss | Recruiting | Phase 1 | 2026-09-24 | NCT07838740 | |
| VK2735 for Weight Management Type 2 Diabetes Phase 3 (VANQUISH 2) | Body Weight, Body Weight Changes, Pathological Conditions, Signs and Symptoms, Signs and Symptoms, Weight Loss | Active, not recruiting | Phase 3 | 2026-04-07 | NCT07104383 | |
| VK2735 for Weight Management Phase 3 | Body Weight, Body Weight Changes, Pathological Conditions, Signs and Symptoms, Signs and Symptoms, Weight Loss | Active, not recruiting | Phase 3 | 2025-11-24 | NCT07104500 |